Race and improvements in the use of guideline-recommended therapies for patients with heart failure: Findings from IMPROVE HF

Journal of the National Medical Association

Volumn 104, Issue 5-6, 2012, Pages 287-298

  Reynolds, Dwight ^a   Albert, Nancy M ^b   Curtis, Anne B ^c   Gheorghiade, Mihai ^d   Heywood, J Thomas ^e   McBride, Mark L ^f   Inge, Patches Johnson ^f   Mehra, Mandeep R ^g   O'Connor, Christopher M ^h   Walsh, Mary Norine ⁱ   Yancy, Clyde W ^d   Fonarow, Gregg C ^j  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e SCRIPPS CLINIC   (United States)

^f Outcome Sciences Inc   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ St Vincent Heart Center of Indiana   (United States)

^j UCLA MEDICAL CENTER   (United States)

more..

Author keywords

Guidelines; Heart failure; Quality of care; Race ethnicity

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUCASIAN; DEFIBRILLATOR; EVIDENCE BASED PRACTICE; FEMALE; HEALTH EDUCATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEGRO; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE;

EID: 84865443947     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30156-5     Document Type: Article

References (27)

1. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068-3072.
2. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.
3. National Heart, Lung, and Blood Institute. Cardiovascular diseases. In: Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 2009:19-57. www.nhlbi.nih.gov/resources/docs/2009- ChartBook.pdf. Accessed February 2, 2011.
4. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;101(7):1016-1022.
5. Schappert SM, Rechsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Rep. 2008;(8):1-29.
6. Centers for Medicare and Medicaid Services. Health care financing review. In: Medicare & Medicaid Statistical Supplement. 2010 ed. Baltimore, MD: Centers for Medicare and Medicaid Services; 2010. www.cms.hhs.gov/ MedicareMedicaidStatSupp/. Accessed June 8, 2011.
7. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360(12):1179-1190.
8. Yancy CW. Heart failure in African Americans: a cardiovascular enigma. J Card Fail. 2000;6(3):183-186.
9. Yancy CW, Strong M. The natural history, epidemiology, and prognosis of heart failure in African Americans. Congest Heart Fail. 2004;10(1):15-18.
10. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021-1028.
11. Yancy CW, Abraham WT, Albert NM, et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51(17):1675-1684.
12. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation; endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.
13. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111(10):1233-1241.
14. Albert NM, Fonarow GC, Abraham WT, et al. Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF. J Card Fail. 2007;13(3):189-196.
15. Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm. 2009;6(3):325-331.
16. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298(13):1525-1532.
17. Piccini JP, Hernandez AF, Dai D, et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation. 2008;118(9):926-933.
18. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation. 2005;111(10):1332-1336.
19. Mensah GA, Dunbar SB. A framework for addressing disparities in cardiovascular health. J Cardiovasc Nurs. 2006;21(6):451-456.
20. Peterson E, Yancy CW. Eliminating racial and ethnic disparities in cardiac care. N Engl J Med. 2009;360(12):1172-1174.
21. Fonarow GC, Yancy CW, Albert NM, et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007;154(1):12-38.
22. Wynia MK, Ivey SL, Hasnain-Wynia R. Collection of data on patients' race and ethnic group by physician practices. N Engl J Med. 2010;362(9):846-850.
23. Braun L, Fausto-Sterling A, Fullwiley D, et al. Racial categories in medical practice: how useful are they? PLoS Med. 2007;4(9):e271.
24. Chin MH, Huminowski CA. When is risk stratification by race or ethnicity justified in medical care? Acad Med. 2002;77(3):202-208.
25. Fonarow GC, Abraham WT, Albert NM, et al. Influence of a performance-improvement initiative on quality of care for patients hospitalizedwith heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167(14):1493-1502.
26. Schwamm LH, Reeves MJ, Pan W, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121(13):1492-1501.
27. Cohen MG, Fonarow GC, Peterson ED, et al. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation. 2010;121(21):2294-2301.